Assessment of lymphopenia in patients with multiple sclerosis treated with dimethyl fumarate in a real clinical setting

被引：0
|
作者：
Alroughani, Raed [1 ]
Ahmed, Samar [2 ]
Behbehani, Raed [2 ]
Al-hashel, Jasem [3 ]
机构：
[1] Amiri Hosp, Kuwait, Kuwait
[2] Ibn Sina Hosp, Kuwait, Kuwait
[3] Kuwait Univ, Kuwait, Kuwait
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
47
引用
收藏
页码：NP18 / NP18
页数：1
相关论文
共 50 条
  • [31] COVID-19 in multiple sclerosis patients treated with dimethyl fumarate
    Fioravante Capone
    Elisabetta Ferraro
    Francesco Motolese
    Vincenzo Di Lazzaro
    Journal of Neurology, 2021, 268 : 3132 - 3134
  • [32] COVID-19 in multiple sclerosis patients treated with dimethyl fumarate
    Capone, Fioravante
    Ferraro, Elisabetta
    Motolese, Francesco
    Di Lazzaro, Vincenzo
    JOURNAL OF NEUROLOGY, 2021, 268 (09) : 3132 - 3134
  • [33] Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis
    Sainz de la Maza, Susana
    Sabin Munoz, Julia
    Pilo de la Fuente, Belen
    Thuissard, Israel
    Andreu-Vazquez, Cristina
    Galan Sanchez-Seco, Victoria
    Salgado-Camara, Paula
    Costa-Frossard, Lucienne
    Monreal, Enric
    Ayuso-Peralta, Lucia
    Garcia-Vasco, Lorena
    Manuel Garcia-Dominguez, Jose
    Luisa Martinez-Gines, Maria
    Munoz Fernandez, Carmen
    Diaz-Diaz, Judit
    Oreja-Guevara, Celia
    Gomez-Moreno, Mayra
    Martin, Hugo
    Rubio-Flores, Laura
    Rosario Blasco, Maria
    Maria Villar-Guimerans, Luisa
    Aladro, Yolanda
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 59
  • [34] Dimethyl Fumarate in Relapsing Remitting Multiple Sclerosis: Effects of Dose Reduction on Lymphopenia
    Wong, Ka-Ho
    Marini, Erica
    Clardy, Stacey
    DeWitt, L.
    Klein, Julia
    Soldan, M. Paz
    Rose, John
    NEUROLOGY, 2017, 88
  • [35] Factors associated with dimethyl fumarate induced lymphopenia in a rural multiple sclerosis cohort
    Malik, M. T.
    Zhang, Y.
    Lee, M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 572 - 572
  • [36] Progressive multifocal leukoencephalopathy in a patient treated by dimethyl fumarate for multiple sclerosis with no lymphopenia but exhausted T lymphocyte subpopulations
    Garcia, J.
    Baroni, H. Chavez
    Dubessy, A. L.
    Giannesini, C.
    Taoufik, Y.
    Stankoff, B.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 556 - 556
  • [37] Clinical effectiveness of dimethyl fumarate in multiple sclerosis patients from Argentina
    Contentti, Edgar Carnero
    Alonso, Ricardo
    Silva, Berenice
    Burgos, Marcos
    Tavolini, Dario
    Lopez, Pablo
    Cristiano, Edgardo
    Patrucco, Liliana
    Tkachuk, Veronica
    Mainella, Carolina
    Zanga, Gisella
    Leguizamon, Felisa
    Luetic, Geraldine
    Silva, Emanuel
    Tizio, Santiago
    Serena, Marina Alonso
    Rojas, Juan Ignacio
    NEUROLOGICAL SCIENCES, 2024, 45 (12) : 5833 - 5840
  • [38] Effectiveness of Dimethyl Fumarate in Japanese Patients with Multiple Sclerosis in Clinical Practice
    Saida, T.
    Yokoyama, K.
    Ohashi, T.
    Sato, R.
    Makioka, H.
    Sato, Y.
    Onizuka, Y.
    Matsuda, N.
    Torii, S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP59 - NP60
  • [39] Age influences lymphopenia in MS patients treated with dimethyl-fumarate
    Mancinelli, C. R.
    Scarpazza, C.
    Rasia, S.
    De Rossi, N.
    Cordioli, C.
    Capra, R.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 506 - 507
  • [40] T and B Cell Driven Dimethyl Fumarate-Induced Lymphopenia in Patients with Multiple Sclerosis.
    Lee, J.
    Dunn, J.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (03) : 421 - 422
12345